fda glp-1 warning september 2025 Beyond the Headlines: Letters to Compounders Safe use of compounded GLP

Niacinamide is sometimes included in GLP-1 formulations to support energy pathways and improve overall metabolic function

Semaglutide (subcutaneous) and influenza vaccine (intramuscular) should be administered at different anatomical sites, preferably different limbs, if given on the same day

doi: 10.3389/fmicb.2020.607735 31 Mercado-MonroyJFalfn-CortsRNMuz-PrezVMGmez-AldapaCACastro-RosasJ

Research published in the Journal of the American Medical Association found that GLP-1 drug users faced a higher risk of gastroparesis compared to users of other weight loss medications or diabetes drugs

Notably, it produces Wegovy and Ozempic, both of which are FDA-approved semaglutide medications

Not pharmaceutical-level weight loss or appetite suppression